Literature DB >> 11756942

Topical tacrolimus in the treatment of symptomatic oral lichen planus: a series of 13 patients.

Todd W Rozycki1, Roy S Rogers, Mark R Pittelkow, Marian T McEvoy, Rokea A el-Azhary, Alison J Bruce, Joseph P Fiore, Mark D P Davis.   

Abstract

BACKGROUND: Oral lichen planus (OLP) is a relatively common, chronic inflammatory condition, which frequently presents with symptoms of pain and irritation. OLP is often difficult to manage. Therefore there is a need for more effective and safer therapies for symptomatic OLP.
OBJECTIVE: Our purpose was to determine the effectiveness of topical tacrolimus as therapy for symptomatic OLP.
METHODS: A retrospective review was performed of 13 patients with symptomatic OLP treated with topical tacrolimus between September 1999 and September 2000.
RESULTS: Eleven of the 13 patients reported definite symptomatic response to treatment and 2 had no response. Eight patients had a partial response, whereas 3 patients had a complete response with respect to lesion clearance. Seven of the responding patients had no flares with continued treatment. The other 4 patients noted flares soon after stopping the treatment. Side effects were rare and minor.
CONCLUSIONS: In this retrospective case series of 13 patients, topical tacrolimus was well tolerated and appeared to be an effective therapy to control symptoms and clear lesions of OLP.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11756942     DOI: 10.1067/mjd.2002.119648

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  13 in total

Review 1.  [Topical corticosteroids versus topical inhibitors of calcineurin].

Authors:  R Niedner
Journal:  Hautarzt       Date:  2003-02-28       Impact factor: 0.751

Review 2.  [Practice experience with topical calcineurin inhibitors].

Authors:  J Lübbe
Journal:  Hautarzt       Date:  2003-04-01       Impact factor: 0.751

Review 3.  Tacrolimus ointment: a review of its use in atopic dermatitis and its clinical potential in other inflammatory skin conditions.

Authors:  Dene Simpson; Stuart Noble
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 4.  Clinical features and management of oral lichen planus (OLP) with emphasis on the management of hepatitis C virus (HCV)-related OLP.

Authors:  Alexandru Mester; Ondine Lucaciu; Lidia Ciobanu; Dragos Apostu; Aranka Ilea; Radu Septimiu Campian
Journal:  Bosn J Basic Med Sci       Date:  2018-08-01       Impact factor: 3.363

5.  The Efficacy of Topical Hyaluronic Acid 0.2% in the Management of Symptomatic Oral Lichen Planus.

Authors:  Rahul Raviraj Shetty; Krishna Nagappa Burde; Kruthika Satyabodh Guttal
Journal:  J Clin Diagn Res       Date:  2016-01-01

6.  Treatment of symptomatic oral lichen planus (OLP) with 0.1% tacrolimus powder in Oraguard-B - A pilot prospective study.

Authors:  Upender Malik; Siddharth Gupta; Shilpa D Malik; Shirin Vashishth; M S Raju
Journal:  Saudi Dent J       Date:  2012-06-26

7.  Oral lichen planus treated with tacrolimus 0.1%.

Authors:  João Paulo Marinho Resende; Maria das Graças Afonso Miranda Chaves; Fernando Monteiro Aarestrup; Beatriz Vieira Aarestrup; Sergio Olate; Henrique Duque Netto
Journal:  Int J Clin Exp Med       Date:  2013-10-25

8.  Disappearance of Oral Lichen Planus After Liver Transplantation for Primary Biliary Cirrhosis and Immunosuppressive Therapy in a 63-year-Old Japanese Woman.

Authors:  Yumiko Nagao; Michio Sata
Journal:  Hepat Mon       Date:  2014-03-11       Impact factor: 0.660

9.  The comparison of efficacy of adcortyl ointment and topical tacrolimus in treatment of erosive oral lichen planus.

Authors:  Arash Azizi; Shirin Lawaf
Journal:  J Dent Res Dent Clin Dent Prospects       Date:  2007-12-20

Review 10.  Disease scoring systems for oral lichen planus; a critical appraisal.

Authors:  Jing Wang; Isaäc van der Waal
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2015-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.